Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality

NCT00622037 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

NETWORK

Sponsor class

Conditions

Dry Eye

Interventions

DRUG: PEG-400 based artificial tear
DRUG: Systane

Sponsor

Bp Consulting, Inc